Fox Run Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Fox Run Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-12,838	Closed	-$106K	–	570
2019 Q3	$106K	Buy	+12,838	New	+$104K	0.1%	333
2019 Q1	–	Sell	-12,300	Closed	-$108K	–	747
2018 Q4	$108K	Buy	+12,300	New	+$157K	0.06%	461
2018 Q3	–	Sell	-20,217	Closed	-$424K	–	884
2018 Q2	$424K	Buy	20,217 +5,713	+39%	+$106K	0.13%	310
2018 Q1	$233K	Buy	+14,504	New	+$287K	0.06%	581
2016 Q4	–	Sell	-14,300	Closed	-$67K	–	718
2016 Q3	$67K	Sell	14,300 -32,200	-69%	-$191K	0.04%	461
2016 Q2	$306K	Buy	+46,500	New	+$329K	0.15%	280

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fox Run Management's SPPI Position: Q4 2019 in Review

Fox Run Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2019, closing a stake of 12,838 shares — an estimated $106K sold.

Fox Run Management first reported a position in SPPI in Q2 2016 and held it in 6 quarters. The position peaked at $424K in Q2 2018. 169 funds tracked by Wall St. Rank hold SPPI as of Q4 2019.

Fox Run Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2019 after selling out during the quarter.
Fox Run Management sold 12,838 Spectrum Pharmaceuticals Inc shares in Q4 2019, an estimated $106K.
Fox Run Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2016 and held it in 6 quarters.
Fox Run Management's Spectrum Pharmaceuticals Inc position peaked at $424K in Q2 2018.
169 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2019.

Based on Fox Run Management's 13F filing for Q4 2019, filed 14 Feb 2020.